441 related articles for article (PubMed ID: 32686774)
1. Multiple sclerosis and COVID-19.
Mares J; Hartung HP
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Sep; 164(3):217-225. PubMed ID: 32686774
[TBL] [Abstract][Full Text] [Related]
2. Are patients with multiple sclerosis (MS) at higher risk of COVID-19 infection?
Ghajarzadeh M; Bonavita S
Neurol Sci; 2020 Sep; 41(9):2315-2316. PubMed ID: 32638135
[No Abstract] [Full Text] [Related]
3. Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination.
Zheng C; Kar I; Chen CK; Sau C; Woodson S; Serra A; Abboud H
CNS Drugs; 2020 Sep; 34(9):879-896. PubMed ID: 32780300
[TBL] [Abstract][Full Text] [Related]
4. The COVID-19 pandemic and the use of MS disease-modifying therapies.
Giovannoni G; Hawkes C; Lechner-Scott J; Levy M; Waubant E; Gold J
Mult Scler Relat Disord; 2020 Apr; 39():102073. PubMed ID: 32334820
[No Abstract] [Full Text] [Related]
5. A Call for a Three-Tiered Pandemic Public Health Strategy in Context of SARS-CoV-2.
Hanley BP; Keen S; Church G
Rejuvenation Res; 2020 Aug; 23(4):281-283. PubMed ID: 32539623
[No Abstract] [Full Text] [Related]
6. Cell-Free Therapies: Novel Approaches for COVID-19.
Maron-Gutierrez T; Rocco PRM
Front Immunol; 2020; 11():583017. PubMed ID: 33072130
[No Abstract] [Full Text] [Related]
7. Multiple Sclerosis Disease-Modifying Therapies in the COVID-19 Era.
Ciotti JR; Grebenciucova E; Moss BP; Newsome SD
Ann Neurol; 2020 Dec; 88(6):1062-1064. PubMed ID: 32951235
[No Abstract] [Full Text] [Related]
8. Immune status could determine efficacy of COVID-19 therapies.
Cully M
Nat Rev Drug Discov; 2020 Jul; 19(7):431-434. PubMed ID: 32546768
[No Abstract] [Full Text] [Related]
9. Probiotics in Treatment of Viral Respiratory Infections and Neuroinflammatory Disorders.
Shahbazi R; Yasavoli-Sharahi H; Alsadi N; Ismail N; Matar C
Molecules; 2020 Oct; 25(21):. PubMed ID: 33105830
[TBL] [Abstract][Full Text] [Related]
10. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).
Chang FY; Chen HC; Chen PJ; Ho MS; Hsieh SL; Lin JC; Liu FT; Sytwu HK
J Biomed Sci; 2020 Jun; 27(1):72. PubMed ID: 32498686
[TBL] [Abstract][Full Text] [Related]
11. COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies.
Bergmann CC; Silverman RH
Cleve Clin J Med; 2020 Jun; 87(6):321-327. PubMed ID: 32366502
[No Abstract] [Full Text] [Related]
12. COVID-19 and the newly rediscovered multidisciplinarity.
Bersanelli M
Immunotherapy; 2020 Oct; 12(15):1101-1103. PubMed ID: 32957828
[No Abstract] [Full Text] [Related]
13. Obesity, COVID-19 and immunotherapy: the complex relationship!
Finelli C
Immunotherapy; 2020 Oct; 12(15):1105-1109. PubMed ID: 32677493
[No Abstract] [Full Text] [Related]
14. Cytokine storm and the prospects for immunotherapy with COVID-19.
Calabrese LH
Cleve Clin J Med; 2020 Jun; 87(7):389-393. PubMed ID: 32393592
[TBL] [Abstract][Full Text] [Related]
15. Coronavirus pandemic (COVID-19): what speech therapists should know.
Freitas AS; Zica GM; Albuquerque CL
Codas; 2020; 32(3):e20200073. PubMed ID: 32578693
[No Abstract] [Full Text] [Related]
16. Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment.
Abid MB; Mughal M; Abid MA
JAMA Oncol; 2020 Oct; 6(10):1529-1530. PubMed ID: 32433719
[No Abstract] [Full Text] [Related]
17. Implications of COVID-19 Outbreak on Immune Therapies in Multiple Sclerosis Patients-Lessons Learned From SARS and MERS.
Möhn N; Pul R; Kleinschnitz C; Prüss H; Witte T; Stangel M; Skripuletz T
Front Immunol; 2020; 11():1059. PubMed ID: 32477373
[TBL] [Abstract][Full Text] [Related]
18. Keeping standards of multiple sclerosis care through the COVID-19 pandemic.
Sastre-Garriga J; Tintoré M; Montalban X
Mult Scler; 2020 Sep; 26(10):1153-1156. PubMed ID: 32552382
[No Abstract] [Full Text] [Related]
19. COVID-19 will change MS care forever - Yes.
Meca-Lallana V
Mult Scler; 2020 Sep; 26(10):1147-1148. PubMed ID: 32567486
[No Abstract] [Full Text] [Related]
20. SARS-CoV-2: What do we know so far?
Khedkar PH; Patzak A
Acta Physiol (Oxf); 2020 Jun; 229(2):e13470. PubMed ID: 32220035
[No Abstract] [Full Text] [Related]
[Next] [New Search]
